CureVac N.V.

2.87
0.15 (5.51%)
At close: Apr 02, 2025, 3:59 PM
2.82
-1.57%
After-hours: Apr 02, 2025, 07:55 PM EDT

CureVac Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Revenue 53.76M 67.42M 102.99M 48.9M 17.42M 12.87M
Cost of Revenue 124.37M 183.99M 238.19M 14.17M 27.98M 17.74M
Gross Profit -70.61M -116.57M -135.21M 34.73M -10.57M -4.87M
Operating Income -274.21M -249.46M -412.26M -124M -99.5M -72.82M
Interest Income 16.73M 4.01M 10.1M 2.07M 833K 1.97M
Pretax Income -259.97M -249.16M -412.5M -129.8M -100.13M -71.13M
Net Income -260.17M -249.03M -411.72M -129.07M -99.87M -71.24M
Selling & General & Admin 76.43M 89.41M 88.94M 45.76M 43.94M 21.5M
Research & Development 115.72M 62.55M 815.91M 113.81M 43.24M 41.72M
Other Expenses 11.44M -17.68M -627.79M -870K 1.75M 4.73M
Operating Expenses 203.6M 134.28M 277.06M 158.7M 88.93M 67.95M
Interest Expense 2.49M 3.71M 10.34M 22.1M 1.46M 275K
Selling & Marketing Expenses 424K 417K 1.74M 733K 1.75M 1.08M
Cost & Expenses 327.96M 318.27M 515.25M 158.7M 116.91M 85.69M
Income Tax 198K -126K -782K -726K -252K 110K
Shares Outstanding (Basic) 220.48M 189.07M 186.01M 132.2M 186.91M 175.97M
Shares Outstanding (Diluted) 220.83M 189.07M 186.01M 132.2M 186.91M 175.97M
EPS (Basic) -1.18 -1.32 -2.21 -0.98 -0.53 -0.4
EPS (Diluted) -1.18 -1.32 -2.21 -0.98 -0.53 -0.4
EBITDA -234.09M -209.39M -386.49M -123.09M -91.5M -69.85M
EBIT -257.48M -245.45M -402.16M -107.75M -98.67M -70.86M
Depreciation & Amortization 23.39M 26.16M 35.88M 13.61M 4.76M 3.89M